At its core, GPT-Rosalind is the first in a new series of models optimized for scientific workflows. While previous ...

A team of University of Alberta researchers has developed a cardio-oncology drug that protects the heart from chemotherapy ...

Scientists in Glasgow are launching a new Cancer Research UK-funded project to find a way to stop bowel cancer cells ...

Enzymes called proteases act like molecular scissors for proteins in the body and play a role in therapies to stop viruses ...

How does the gut talk to the brain? A new study identifies polysaccharides and peptidoglycans as the key bacterial signals ...

Aston University bioscientist Dr John Reynolds has won a £125,000 Springboard grant from the Academy of Medical Sciences (AMS) for research into neurodegeneration caused by a rare genetic disease.

Target identification is the first and perhaps most critical step in drug discovery and development. Although the human genome contains roughly 20,000 protein-coding genes, only about 4,500 are ...

Technion researchers part of international study that validates fast, accessible alternative to genomic tests using routine ...

We need investment in precision medicine technologies to start programming cancer against itself, writes Cyriac Roeding.

Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene ...

Scientists in Glasgow are launching a new Cancer Research UK-funded project to find a way to stop bowel cancer cells hijacking the body.